Insulin resistance: current therapeutic approaches.
Insulin resistance, an impaired biological response to either exogenous or endogenous insulin occurs in a majority of the diabetic population with type II diabetes. One of the current approaches for treating insulin resistance associated with NIDDM is the use of insulin sensitizing agents. Elucidation of the mechanism(s) of these agents may provide new targets for which selective ligands with better efficacy and low toxicity can be found.